Ahmad Trad

Effective treatment of severe COVID-19 patients with tocilizumab

Minimal Interleukin 6 (IL-6) Receptor Stalk Composition for IL-6 Receptor Shedding and IL-6 Classic Signaling

Discoveries in structure and physiology of mechanically activated ion channels

The Role of Microbes in Developmental Immunologic Programming

Immunogenicity of therapeutic proteins: Influence of aggregation

IL-6 as a keystone cytokine in health and disease

Role of ubiquitination and proteolysis in the regulation of pro- and anti-apoptotic TNF-R1 signaling

Inflammation and tumor progression: signaling pathways and targeted intervention

Aptamers as targeted therapeutics: current potential and challenges

Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Hallmarks of Cellular Senescence

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>

Interleukin-6 and its receptors: A highly regulated and dynamic system

The Interleukin-1 Family: Back to the Future

NF-κB, inflammation, immunity and cancer: coming of age

iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

Cytokine Storm

Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies

Senescence‐associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding

Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes

Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy

The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis

A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)

The membrane‐proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin‐6 receptor and interleukin‐1 receptor II

Thymus-independent type 2 antigen induces a long-term IgG-related network memory

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17

Benefits and burden of the maternally-mediated immunological imprinting

A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells